Training healthcare providers to increase CGM prescriptions for Type 2 Diabetes patients
Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes
This study is testing if training healthcare providers can help them prescribe more continuous glucose monitors to people with Type 2 Diabetes, especially in a mostly Hispanic/Latino community.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 318 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | San Diego State University Academic / other |
| Locations | 2 sites (El Centro, California and 1 other locations) |
| Trial ID | NCT06638099 on ClinicalTrials.gov |
What this trial studies
This interventional study evaluates whether training healthcare professionals can enhance the prescription rates of continuous glucose monitors (CGMs) for patients with Type 2 Diabetes in a Federally Qualified Health Center. The study focuses on a predominantly Hispanic/Latino population and aims to assess the impact of CGM prescriptions on diabetes control, measured by Hemoglobin A1c levels. Additionally, it seeks to identify barriers patients face when prescribed and using CGMs. The methodology includes in-person training for healthcare providers on clinical guidelines and insurance eligibility to improve CGM utilization among eligible patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Type 2 Diabetes for at least one year and are current patients at participating Innercare Clinics.
Not a fit: Patients who have newly diagnosed diabetes, diabetes insipidus, diabetes type 1, or gestational diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diabetes management and health outcomes for patients with Type 2 Diabetes through increased access to continuous glucose monitoring.
How similar studies have performed: Other studies have shown success in increasing CGM utilization through provider education, indicating that this approach has potential for positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Participant Eligibility: Inclusion: * adults 18 years or older, * have been diagnosed with T2D at least one year prior to recruitment, * are a current patient of one of the three participating Innercare Clinics with no - * plans to discontinue their care at Innercare within the next 6 months, * can understand and speak in English or Spanish, * have telephone access, * do not plan to move out of the area within the next 6 months. Exclusion: * Plans to move out of the area in the next 6 months * Patients with newly diagnose diabetes mellitus (less than one year), diabetes insipidus, diabetes type 1 or gestational diabetes. Provider/Staff Eligibility: Inclusion * 18 years or older, * able to read and write in English, * currently employed at one of the participating Innercare clinics (Brawley, El Centro, Calexico), * currently be treating at least one adult patient for T2D, scheduled to complete the CGM toolkit training. Exclusion * Personnel without experience providing care to adult patients with T2D in primary care settings.
Where this trial is running
El Centro, California and 1 other locations
- Innercare Inc — El Centro, California, United States (Recruiting)
- Innercare, Inc — El Centro, California, United States (Recruiting)
Study contacts
- Principal investigator: Emily Schmied,, PhD — San Diego State University
- Study coordinator: Julie L Pickrel, MPH
- Email: jpickrel@sdsu.edu
- Phone: 1+ 619-594-3369
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.